Author:
Jujić Amra,Godina Christopher,Belting Mattias,Melander Olle,Juul Holst Jens,Ahlqvist Emma,Gomez Maria F.,Nilsson Peter M.,Jernström Helena,Magnusson Martin
Abstract
AbstractConcerns have been raised regarding a potentially increased risk of cancer associated with treatment with glucagon-like peptide-1 (GLP-1) receptor agonists. Here, we explored whether fasting and oral glucose tolerance test post-challenge glucose-dependent insulinotropic peptide (GIP) and GLP-1 levels were associated with incident first cancer. Within the cardiovascular re-examination arm of the population-based Malmö Diet Cancer study (n = 3734), 685 participants with a previous cancer diagnosis were excluded, resulting in 3049 participants (mean age 72.2 ± 5.6 years, 59.5% women), of whom 485 were diagnosed with incident first cancer (median follow-up time 9.9 years). Multivariable Cox-regression and competing risk regression (death as competing risk) were used to explore associations between incretin levels and incident first cancer. Higher levels of fasting GLP-1 (462 incident first cancer cases/2417 controls) showed lower risk of incident first cancer in competing risk regression (sub-hazard ratio 0.90; 95% confidence interval 0.82–0.99; p = 0.022). No association was seen for fasting GIP, post-challenge GIP, or post-challenge GLP-1 and incident first cancer. In this prospective study, none of the fasting and post-challenge levels of GIP and GLP-1 were associated with higher risk of incident first cancer; by contrast, higher levels of fasting GLP-1 were associated with lower risk of incident first cancer.
Funder
Lunds Universitet
Region Skåne
Medicinska Fakulteten, Lunds Universitet
Vetenskapsrådet
Hjärt-Lungfonden
Crafoordska Stiftelsen
Sydvästra Skånes Diabetesförening
Direktör Albert Påhlssons Stiftelse
Ernhold Lundströms stiftelse
Knut och Alice Wallenbergs Stiftelse
Novo Nordisk Foundation Center for Basic Metabolic Research
Stiftelsen för Strategisk Forskning
Skånes universitetssjukhus
Hulda och E Conrad Mossfelts Stiftelse för Vetenskaplig Forskning Inom Hjärt- och Kärlsjukdomarnas Område
Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
Marcus Wallenbergs Stiftelse för Internationellt Vetenskapligt Samarbete
Lund University
Publisher
Springer Science and Business Media LLC
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献